CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,953,260
- in 5 filings, $6.0M under 10b5-1 plans
Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-14 | BARTHELEMY NICOLAS Director | Grant or award | +995 | 5,436 | ||
| 2026-05-14 | BARTHELEMY NICOLAS Director | Grant or award · Stock Option (Right to Buy) | +2,239 | 2,239 | ||
| 2025-05-15 | BARTHELEMY NICOLAS Director | Grant or award | +973 | 4,441 | ||
| 2025-05-15 | BARTHELEMY NICOLAS Director | Grant or award · Stock Option (Right to Buy) | +1,800 | 1,800 | ||
| 2024-06-14 | BARTHELEMY NICOLAS Director | Purchase | +1,200 | $125.45 | $151K | 4,668 |
| 2024-05-16 | BARTHELEMY NICOLAS Director | Grant or award | +701 | 3,468 | ||
| 2024-05-16 | BARTHELEMY NICOLAS Director | Grant or award · Stock Option (Right to Buy) | +1,376 | 1,376 | ||
| 2023-05-18 | BARTHELEMY NICOLAS Director | Grant or award | +686 | 2,767 | ||
| 2023-05-18 | BARTHELEMY NICOLAS Director | Grant or award · Stock Option (Right to Buy) | +1,487 | 1,487 | ||
| 2022-05-26 | BARTHELEMY NICOLAS Director | Grant or award | +534 | 2,081 | ||
| 2022-05-26 | BARTHELEMY NICOLAS Director | Grant or award · Stock Option (Right to Buy) | +1,298 | 1,298 |
Page 1 of 1 · 11 trades